Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Elanco Animal Health Incorporated Common Stock
(NY:
ELAN
)
12.82
+0.00 (+0.04%)
Streaming Delayed Price
Updated: 10:56 AM EDT, May 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Elanco Animal Health Incorporated Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
ELANCO ANIMAL HEALTH INCORPORATED (NYSE: ELAN) INVESTOR ALERT: Investors With Large Losses in Elanco Animal Health Incorporated Should Contact Bernstein Liebhard LLP To Discuss Their Rights
October 08, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
September 20, 2024
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to...
Via
Benzinga
Exposures
Product Safety
Demystifying Elanco Animal Health: Insights From 4 Analyst Reviews
September 19, 2024
Via
Benzinga
Robinhood To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Thursday
September 19, 2024
Via
Benzinga
A Closer Look at 4 Analyst Recommendations For Elanco Animal Health
July 01, 2024
Via
Benzinga
The Latest Analyst Ratings For Elanco Animal Health
May 09, 2024
Via
Benzinga
Breaking Down Elanco Animal Health: 6 Analysts Share Their Views
February 27, 2024
Via
Benzinga
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
August 13, 2024
Via
Benzinga
Elanco Animal Health (ELAN) Q2 2024 Earnings Call Transcript
August 08, 2024
ELAN earnings call for the period ending June 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ELAN Investors Have Opportunity to Join Elanco Animal Health Incorporated Securities Fraud Investigation with the Schall Law Firm
July 30, 2024
From
The Schall Law Firm
Via
Business Wire
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
July 10, 2024
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.
Via
InvestorPlace
Merk Animal Health Completes Acquisition of Elanco Animal Health Assets
July 09, 2024
Merck Animal Health announced the purchase of Elanco Animal Health's aquaculture business.Merck & Company (NYSE:MRK) completed the acquisition of the aquaculture bus
Via
Benzinga
Citigroup, Elanco Animal Health And A Tech Stock: CNBC's 'Final Trades'
July 09, 2024
Analysts expect Citigroup to report good earnings on Friday. Stephanie Link chose Elanco for its new products. Corning increased its sales guidance.
Via
Benzinga
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
July 05, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
ELAN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorporated (NYSE: ELAN) Investors with Significant Losses to Contact the Firm
July 03, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
ELANCO ALERT: Bragar Eagel & Squire, P.C. is Investigating Elanco Animal Health Incorporated on Behalf of Elanco Stockholders and Encourages Investors to Contact the Firm
July 01, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
June 28, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Elanco Animal Health Shares Sink On Unexpected Label Update For Canine Dermatology Drug
June 27, 2024
Elanco Animal Health shares drop after updates on FDA approval timelines for Zenrelia and Credelio Quattro. Zenrelia's U.S. label includes a boxed warning, impacting adoption. U.S. launches for both...
Via
Benzinga
Exposures
Product Safety
Fluffy's Drugmaker Elanco Animal Health Plummets On Unexpected Safety Warning
June 27, 2024
The company is working on treatments for eczema and parasite prevention.
Via
Investor's Business Daily
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 27, 2024
Via
Benzinga
Bargain Bin: 3 Cheap Stocks to Buy Before Memorial Day
May 23, 2024
Summer has arrived on Wall Street! Discover three cheap stocks to buy with solid fundamentals to boost your profitability this season.
Via
InvestorPlace
Elanco Animal Health's Q1 Earnings Show Improved Base Business, Analyst Highlights Slightly Delayed But Encouraging Pipeline
May 08, 2024
Elanco Animal Health (NYSE: ELAN) reports Q1 results: adjusted EPS $0.34 (-26% Y/Y), sales $1.21B (-4% Y/Y). 2024 guidance: EPS $0.88-$0.96, revenue $4.46-$4.52 billion.
Via
Benzinga
Elanco Animal Health (ELAN) Q1 2024 Earnings Call Transcript
May 08, 2024
ELAN earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 08, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 08, 2024
Via
Benzinga
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
May 08, 2024
Via
Benzinga
ELAN Stock Earnings: Elanco Animal Health Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
ELAN stock results show that Elanco Animal Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Elanco Makes A Bullish Move On Its First Quarter Beat; Are Pet Health Stocks Forging A Comeback?
May 08, 2024
Elanco is the second animal health company to report better-than-expected first-quarter metrics.
Via
Investor's Business Daily
Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members
April 01, 2024
Elanco Animal Health settles with Ancora, expanding board to 14 members, including Ancora's nominees Craig Wallace and Kathy Turner. Ancora's significant stake in Elanco, approximately $250 million,...
Via
Benzinga
Ancora Nominates Four Highly Qualified, Independent Director Candidates and Urges Orderly CEO Succession at Elanco Animal Health
February 29, 2024
From
Ancora Holdings Group, LLC
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.